Wave Life Sciences WVE Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$26.09M+50.9% | -$53.18M+1.2% | -$53.85M-6.7% | -$50.47M-7.7% | -$46.88M— | ||
| $841K-0.4% | $844K-1.4% | $856K-1.0% | $865K-1.1% | $875K-3.5% | ||
| $9.06M+23.3% | $7.35M+13.6% | $6.47M+4.5% | $6.2M+25.1% | $4.95M+52.7% | ||
| -$1.28M+85.4% | -$8.72M-204% | $8.38M+418% | $1.62M+214% | -$1.42M— | ||
| $3.29M— | —— | —— | —— | -$2.05M-159% | ||
| -$13.52M-234% | $10.08M— | —— | —— | -$13.27M-291% | ||
| $751K— | —— | -$4.85M-2,536% | $199K+269% | -$118K-103% | ||
| -$28.25M-373% | -$5.97M— | —— | -$7.08M+22.8% | -$9.18M+88.9% | ||
| $4.83M— | —— | -$47K+96.5% | -$1.36M+8.1% | -$1.48M-44.2% | ||
| -$59.55M-76.3% | -$33.78M+24.4% | -$44.67M+2.9% | -$46.01M+27.0% | -$63.04M-44.4% | ||
| $438K— | $0-100% | $248K-19.0% | $306K+85.5% | $165K+91.9% | ||
| -$438K— | $0+100% | -$248K+19.0% | -$306K-85.5% | -$165K-91.9% | ||
| $1.93M-87.0% | $14.87M+588% | -$3.05M-613% | $594K-75.8% | $2.45M— | ||
| $2.53M-99.4% | $439.7M+1,245% | $32.69M+180% | $11.69M+181% | $4.16M-88.1% | ||
| -$4K— | —— | —— | $43K-25.9% | $58K+156% | ||
| -$57.47M-114% | $405.86M+3,413% | -$12.25M+64.6% | -$34.58M+41.4% | -$58.99M— | ||
| $9.06M+23.3% | $7.35M+13.6% | $6.47M+4.5% | $6.2M+25.1% | $4.95M+52.7% | ||
| $1.46M+3.2% | $1.42M+3.2% | $1.37M+3.2% | $1.33M+3.3% | $1.29M+3.2% | ||
| $841K-0.4% | $844K-1.4% | $856K-1.0% | $865K-1.1% | $875K-3.5% | ||
| -$13.52M-234% | $10.08M— | —— | —— | -$13.27M-291% | ||
| -$2.05M-2.2% | -$2.01M-3.5% | -$1.94M-2.7% | -$1.89M-4.6% | -$1.81M-2.2% | ||
| $751K— | —— | -$4.85M-2,536% | $199K+269% | -$118K-103% | ||
| $4.83M— | —— | -$47K+96.5% | -$1.36M+8.1% | -$1.48M-44.2% | ||
| $0-100% | $52.06M+72.3% | $30.21M+172% | $11.1M+779% | $1.26M-75.2% | ||
| $593K— | —— | $439K— | —— | $442K— | ||
| -$4K— | —— | —— | $43K-25.9% | $58K+156% | ||
| -$28.25M-373% | -$5.97M— | —— | -$7.08M+22.8% | -$9.18M+88.9% | ||
| -$59.99M-77.6% | -$33.78M+24.8% | -$44.91M+3.0% | -$46.32M+26.7% | -$63.2M-44.5% | ||
| -$59.99M-77.6% | -$33.78M+24.8% | -$44.91M+3.0% | -$46.32M+26.7% | -$63.2M-44.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Wave Life Sciences generate?
- Wave Life Sciences (WVE) generated -$184.0M in operating cash flow over the trailing twelve months.
- What is Wave Life Sciences's free cash flow?
- After $992.0K of capital expenditures, Wave Life Sciences's free cash flow was -$185.0M over the trailing twelve months, down 2.0% year over year.
- Where does Wave Life Sciences's cash flow data come from?
- Every line is extracted from Wave Life Sciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
